1
|
Liu M, Jia G, Meng X, Rong Y, Xia Y, Hu Y, He X, He J, Shi H, Liu T, Liu L, Zhou W, Liu R, Bao G, Liu C, Liu Z, Wang F. Cyclic Enrichment of Urinary Exosomes Using a MOF-on-MOF-Based Asymmetric Impinging Streams Chip for Bladder Cancer Diagnosis and Prognosis Prediction. Adv Healthc Mater 2025:e2500848. [PMID: 40296360 DOI: 10.1002/adhm.202500848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2025] [Revised: 04/12/2025] [Indexed: 04/30/2025]
Abstract
Urinary exosomes are valuable biomarkers for the liquid biopsy of bladder cancer (BCa), carrying critical biomolecules associated with BCa that assist in clinical diagnosis and prognosis prediction. However, the lack of rapid, efficient, and high-throughput techniques for urinary exosome enrichment limits their clinical application. This study presents an exosome cyclic enrichment chip based on asymmetric impinging streams and a metal-organic framework (MOF)-on-MOF material. The newly synthesized MOF material exhibited excellent exosome-enrichment capabilities. Moreover, the integration of asymmetric impinging streams and a cyclic fluidic pathway within the chip notably enhanced the collision efficiency between exosomes and MOF. Leveraging the chip, enables the rapid and efficient enrichment of exosomes from a 10 mL urine sample within 30 min, without the requirement for sample pre-concentration. In a clinical study of 300 subjects from two centers, a BCa diagnostic model based on urinary exosomal NORAD (Exo-NORAD) and urine sediment NORAD (Sed-NORAD) is developed, which showed a higher detection positivity rate than BCa fluorescence in situ hybridization (FISH) and urinary cytology. Exo-NORAD is identified as an independent prognostic factor for BCa using Cox regression analysis. In conclusion, this study provides a new approach for the noninvasive diagnosis and prognosis prediction of BCa.
Collapse
Affiliation(s)
- Min Liu
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Gaihua Jia
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Xiangyu Meng
- Health Science Center, Hubei Minzu University, Enshi, 445000, China
| | - Yuan Rong
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Yifan Xia
- National "111" Center for Cellular Regulation and Molecular Pharmaceutics, School of Life and Health Sciences, Hubei University of Technology, Wuhan, 430068, China
| | - Yue Hu
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Xin He
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Jiurong He
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
| | - Hongjie Shi
- Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
| | - Tongzu Liu
- Department of Urology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, China
| | - Lilong Liu
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
| | - Wei Zhou
- Guangzhou Anfang Biotechnology Co., Ltd., Guanzhou, 510182, China
| | - Rui Liu
- Guangzhou Anfang Biotechnology Co., Ltd., Guanzhou, 510182, China
| | - Guangming Bao
- National "111" Center for Cellular Regulation and Molecular Pharmaceutics, School of Life and Health Sciences, Hubei University of Technology, Wuhan, 430068, China
| | - Cheng Liu
- Department of Gynecology and Obstetrics, Renmin Hospital of Wuhan University, Wuhan, 430060, China
| | - Zheng Liu
- Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
| | - Fubing Wang
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
- Hubei Provincial Clinical Research Center for Molecular Diagnostics, Wuhan, 430071, China
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, 430071, China
| |
Collapse
|